Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant
Paul Elliott, David Haw, Haowei Wang, et al.
Science (2021) Vol. 374, Iss. 6574
Open Access | Times Cited: 176

Showing 26-50 of 176 citing articles:

Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future
Fausto Baldanti, Nirmal Kumar Ganguly, Guiqiang Wang, et al.
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 59, Iss. 7, pp. 445-459
Open Access | Times Cited: 27
Variant-specific introduction and dispersal dynamics of SARS-CoV-2 in New York City – from Alpha to Omicron
Simon Dellicour, Samuel L. Hong, Verity Hill, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011348-e1011348
Open Access | Times Cited: 15
SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies
Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1263-1263
Open Access
Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis
Deepti Gurdasani, Samir Bhatt, Anthony Costello, et al.
Journal of the Royal Society of Medicine (2021) Vol. 114, Iss. 11, pp. 513-524
Open Access | Times Cited: 38
Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants
Severino Jefferson Ribeiro da Silva, Suelen Cristina de Lima, Ronaldo Celerino da Silva, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 25
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein
Julia Castro, Patrick O. Azevedo, Marcílio Jorge Fumagalli, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
The challenges of data in future pandemics
Nigel Shadbolt, Alys Brett, Min Chen, et al.
Epidemics (2022) Vol. 40, pp. 100612-100612
Open Access | Times Cited: 23
SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2
Oliver Eales, Andrew J. Page, Leonardo de Oliveira Martins, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number
Oliver Eales, Kylie E. C. Ainslie, Caroline E. Walters, et al.
Epidemics (2022) Vol. 40, pp. 100604-100604
Open Access | Times Cited: 22
Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in the Brazilian State of Amazonas
Ighor Arantes, Gonzalo Bello, Valdinete Alves do Nascimento, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Inference of epidemic dynamics in the COVID-19 era and beyond
Anne Cori, Adam J. Kucharski
Epidemics (2024) Vol. 48, pp. 100784-100784
Open Access | Times Cited: 4
Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models
Daniel J. Sheward, Marco Mandolesi, Egon Urgard, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 11, pp. 100450-100450
Open Access | Times Cited: 27
COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2
Cameron Zachreson, Freya M. Shearer, David J. Price, et al.
Science Advances (2022) Vol. 8, Iss. 14
Open Access | Times Cited: 20
Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events
Rachael Pung, Josh A. Firth, Lewis G. Spurgin, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections
Qinghong Fan, Jingrong Shi, Yanhong Yang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
A large-scale and PCR-referenced vocal audio dataset for COVID-19
Jobie Budd, Kieran Baker, Emma Karoune, et al.
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 3
Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys
Marc Chadeau‐Hyam, David Tang, Oliver Eales, et al.
The Lancet Regional Health - Europe (2022) Vol. 21, pp. 100462-100462
Open Access | Times Cited: 17
Post-peak dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022
Paul Elliott, Oliver Eales, Barbara Bodinier, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 16
Ecological and evolutionary dynamics of multi-strain RNA viruses
Dennis N. Makau, Samantha Lycett, Matthew J. Smith, et al.
Nature Ecology & Evolution (2022) Vol. 6, Iss. 10, pp. 1414-1422
Open Access | Times Cited: 16
Rapid Assessment of SARS-CoV-2 Variant-Associated Mutations in Wastewater Using Real-Time RT-PCR
Kata Farkas, Cameron Pellett, Rachel Williams, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure
Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Selective sweeps in SARS-CoV-2 variant competition
Laura Boyle, Sofia Hletko, Jenny Huang, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 47
Open Access | Times Cited: 15
Evasion of Vaccine-Induced Humoral Immunity by Emerging Sub-Variants of SARS-CoV-2
Takahiko Koyama, Kei Miyakawa, Reitaro Tokumasu, et al.
Future Microbiology (2022) Vol. 17, Iss. 6, pp. 417-424
Open Access | Times Cited: 14
Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study
Marc Chadeau‐Hyam, Oliver Eales, Barbara Bodinier, et al.
EClinicalMedicine (2022) Vol. 48, pp. 101419-101419
Open Access | Times Cited: 14
Breakthrough SARS-CoV-2 infections after COVID-19 immunization
Joshua Hirsh, Thwe Htay, Shubhang Bhalla, et al.
Journal of Investigative Medicine (2022) Vol. 70, Iss. 6, pp. 1429-1432
Open Access | Times Cited: 14

Scroll to top